How will Purdue Pharma settlement funds be distributed to states by end of 2025?
All states receive funds • 25%
Most states receive funds • 25%
Some states receive funds • 25%
No states receive funds • 25%
Official state announcements or reports on fund distribution
Sacklers Increase Purdue Pharma Bankruptcy Settlement Contribution to $6.5 Billion from $6 Billion for Opioid Lawsuits
Jan 13, 2025, 11:35 AM
Members of the Sackler family, owners of Purdue Pharma, have agreed to increase their total contribution to a new bankruptcy settlement related to opioid lawsuits. The revised contribution will amount to approximately $6.5 billion, up from $6 billion under a previous plan. This adjustment comes as part of ongoing legal efforts to address the financial repercussions of the opioid crisis. Reports indicate that the Sacklers' overall wealth has increased since Purdue's bankruptcy filing, attributed to the appreciation of their investment assets and financial holdings.
View original story
Endo International • 25%
Other • 25%
Johnson & Johnson • 25%
Teva Pharmaceuticals • 25%
More than $2 billion • 25%
$1 billion to $1.5 billion • 25%
Less than $1 billion • 25%
$1.5 billion to $2 billion • 25%
Rebrand or restructure • 25%
No significant actions • 25%
Reach new settlements with other firms • 25%
File for bankruptcy again • 25%
$500 million to $1 billion • 25%
Less than $500 million • 25%
$1 billion to $2 billion • 25%
More than $2 billion • 25%
50% to 75% • 25%
More than 75% • 25%
Less than 25% • 25%
25% to 50% • 25%
Yes • 50%
No • 50%
More negative • 25%
Mixed opinions • 25%
Unchanged • 25%
Less negative • 25%